← Leaderboards
Douglas Anthony Pippin
Toph Biologicals, Inc.
$3,976,377
Attributed
$8,300,467
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2010–24$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,300,467 · 7
By mechanism
R44$7,249,117 · 3
R43$1,051,350 · 4
Top collaborators
- Daniel J Canney8 shared
- Benjamin Blass7 shared
- Ellen Ann Walker3 shared
- Carlos A Barrero1 shared
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingDoseAcuteLeadSerotonin 7 ReceptorDrug KineticsIn VivoSerotoninChronicProgramsPlasmaPermeabilityMedicalPharmaceutical PreparationsIn VitroBinding ProteinsReceptorLinkExhibitsEfficacy StudySeriesPharmacologyBrain RegionBrain
Grant awards (11)
In Vivo Characterization of 5-HT7 Modulators in Rat Models of Cocaine Use Disorder$1,250,000
R44 · FY2024 · DA · contact PI
IND Enabling Studies for the Development of Pruritus Therapeutic PRA-523$728,119
R44 · FY2024 · AR · contact PI
In Vivo Characterization of 5-HT7 Modulators in Rat Models of Cocaine Use Disorder$1,250,000
R44 · FY2023 · DA · contact PI
IND Enabling Studies for the Development of Pruritus Therapeutic PRA-523$1,244,708
R44 · FY2023 · AR · contact PI
In Vivo Characterization of 5-HT7 Modulators in Rat Models of Cocaine Use Disorder$320,000
R44 · FY2022 · DA · contact PI
Novel 5-HT7 Antagonists for the Treatment of Pruritus$275,544
R43 · FY2022 · AR · contact PI
Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease$1,228,145
R44 · FY2019 · DK · contact PI
In vivo Characterization of PRA078C in the Rat Cocaine Reinstatement Model$350,000
R43 · FY2019 · DA · contact PI
Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease$1,228,145
R44 · FY2018 · DK · contact PI
Novel 5-HT7 Antagonists for the treatment of inflammatory bowel disease$231,801
R43 · FY2017 · DK · contact PI
Novel Reagents For The Detection Of Low Abundance Cancer Specific Glycoforms$194,005
R43 · FY2010 · CA · contact PI